SYNTARA LIMITED ASX News

30 July 2024

Quarterly Activities Report

Syntara announces significant progress in clinical trials for myelofibrosis and myelodysplastic syndrome.

Syntara Clinical Trials Myelofibrosis Myelodysplastic Syndrome Stock Market News

Posted on: 30/07/2024

Read More
Quarterly Appendix 4C Cash Flow Report

Syntara Limited reveals significant cash flow details for the quarter ending June 2024.

Syntara Limited Quarterly Cash Flow Stock Market News Financial Report

Posted on: 30/07/2024

Read More
Equity Raising Presentation

Syntara Limited announces a $5 million equity raising for clinical program funding.

Syntara Limited Equity Raising Clinical Trials Stock Market News Biotechnology

Posted on: 30/07/2024

Read More
Placement

Syntara Ltd raises A$5 million to fund Phase 2 clinical trials.

Syntara Ltd Stock Market News Clinical Trials Biotechnology Pharmaceuticals

Posted on: 30/07/2024

Read More